"As for the other two compensations?"
In the office.
Upon hearing Xu Yun's words...
Tian Liangwei straightened up, shifting to a more comfortable position in his seat, and continued:
"The second compensation is relatively long-term, and you may not see any effect in the short term—this compensation, provided that you pass the basic review, allows your application to be submitted to a meeting of 100 people (A level) once."
Click--
Xu Yun's expression remained unchanged upon hearing this, but the grip on the chair's armrest suddenly tightened considerably.
The "books" Tian Liangwei mentioned were not the H-comics on Banman Paradise, and the "meeting" he referred to also had another meaning.
Both of these terms are related to Huaxia's scientific research funds.
As mentioned before.
In addition to the academic degree system of Bachelor's, Master's, Doctorate, Associate Professor, and Professor, Huaxia's scientific research system also has another special sequence.
Those are: Qingjian, Youqing, Qingjiang, Qingqian, Outstanding Young Scholar, Changjiang Scholar, and Daqian.
In the youth sector.
The lowest rank is "Young Scientist" (青尖), and the highest rank is "Outstanding Young Scholar).
The Outstanding Young Scholar Fund is comparable to the Changjiang Scholar and Daqian Scholars, representing the pinnacle of the "Young Scientists" category.
Besides that.
Some organizations also select top talents in the industry through their own channels.
For example, various provincial-level "helmet-type" scholars:
Taishan Scholars, Furong Scholars, Sanqin Scholars, West Lake Scholars, the Twelve Heavenly Kings of Yuewen, and so on.
However, there is currently only one organization in China that can rival the national-level "Four Young Talents" awards.
That's the Chinese Academy of Sciences' Hundred Talents Program.
Of course.
The Hundred Talents Program is also divided into three types based on rank.
The lowest level is the Hundred Talents Program C, named "[Young Talents]".
Next is the Hundred Talents Program B, named [Technical Elite].
Above that is the highest level, quasi-national level, the Hundred Talents A, [Academic Leader] -- these seemingly cheesy titles are not made up by the author, but are real.
Among them, the top 100 A-level talents are at least on par with Qingjiang, and the top 50% are equivalent to the Outstanding Young Scholar.
Since there are talent categories, there naturally needs to be a selection process.
This selection process is what's called 'the meeting'.
This will have a rather awkward name: the "Miandiqing Project Review".
Actually, this term is an abbreviation for General Project/Young Scientists Fund Project/Regional Science Fund Project, which is one character taken from each of these categories.
"Submitting to the meeting" means that you write your project proposal into a tender document and submit it.
Next, based on the results of the peer review, the National Natural Science Foundation of China (NSFC) uses its review system to compile the corresponding scores and rankings.
Those who have applied for this program should know this.
Projects submitted to the review meeting are automatically graded based on the feedback received from the experts. Each project is assigned a score corresponding to its review result (A, B, or C) based on the expert review comments.
This means assigning "priority funding", "funding", and "no funding" to different levels, with each level receiving a certain score, and the final score is calculated.
Typically, a grant application for the National Natural Science Foundation of China (NSFC) or the National Natural Science Foundation of China (NSFC) will have 3-5 reviewers. For example, most grant applications for the National Natural Science Foundation of China (NSFC) for young scientists and those in the medical field will have 3 reviewers, while those for the National Natural Science Foundation of China (NSFC) for regional and general programs will have 5 reviewers.
Another special case is the Outstanding Young Scholar Fund, which involves peer review within a small group of researchers. Researchers can voluntarily request to recuse themselves from the review process, including three individuals.
So the reason why children of academicians are more likely to be promoted to the "Young Scientists" program is as follows:
Most academicians become members of the review panel for their respective departments. Although they are required to recuse themselves from the selection process for their own students, the relationships between the review panel members still exist.
Sometimes, if student A submits their application this year, student B might submit theirs next year, so A and B will do each other a favor.
This situation isn't widespread, but it's not uncommon either—in fact, it's the same on the Across the sea.
Throughout history and across the world, every industry values personal relationships and interactions.
The difference lies in the fact that some people understand where the "degree" is, while others are more unscrupulous in forming academic cliques.
All in all.
With new generations joining the workforce every year, the competition becomes increasingly fierce.
If one of the review experts gives a C, it will significantly lower the total score when calculating the overall score.
Getting on the meeting is much more difficult.
In his past life, Xu Yun's proposal failed at this stage, receiving only a 2B+1C, just a hair's breadth away from success.
However, if Xu Yun had actually attended a high-ranking official's gathering in his previous life, this book probably wouldn't have been involved in anything.
In addition, since the applications are for grants, people generally refer to those who have successfully passed the review as "bros," those who have passed multiple times as "gay guys," and those who have failed repeatedly as "dead gay guys."
Ahem, let's get back to the main topic.
As the only quasi-national-level talent selection program, the treatment of the "Hundred Talents A" is even higher than that of most positions in the "Four Young Pioneers".
For example, Fujian Province University offered 800,000 yuan in start-up funding to the 100-person A program, and even allowed for deficits.
This situation has made the spots for the "Top 100" award extremely sought after and highly prestigious.
To some extent, this can be analyzed.
This is also one of the important factors that has enabled the Chinese Academy of Sciences to possess such strong scientific research capabilities today.
To be honest.
The list of 100 people from the Chinese Academy of Sciences was indeed within Xu Yun's plan.
However, Xu Yun's plan is not for now, but for three to four years from now.
At the same time, the goal of the selection is not to select 100 people as A, but rather 100 people as C or at most 100 people as B.
The youngest person selected for the Hundred Talents Program (A level) is Zhou Qi, who is now the Chinese Academy of Sciences and an academician of the Chinese Academy of Sciences.
In 2001, he resolutely turned down the offer from the Gallic Academy of Sciences and returned to his home country, becoming the youngest member of the Hundred Talents Program at the age of 31.
Therefore, in Xu Yun's view, it was quite astonishing that he could be among the top 100 in the A-level competition at the age of 27 or 28.
The result was unexpected.
The Academy of Sciences has actually gone to such lengths this time, allowing him to take the top 100 A-level exam again?
You need to know.
These days, the Huaxia scientific research community is already quite controversial, and many people would rather keep a low profile.
In this case.
The Academy of Sciences actually dared to make this promise to Xu Yun. If Xu Yun really gets selected as one of the top 100 A's...
That's probably going to be another barrage of criticism.
Looking at Xu Yun's subtle expression, Tian Liangwei hesitated for a moment before speaking:
"Little Xu, I can roughly guess what you're thinking. Actually, there's not a consensus within the Academy of Sciences regarding agreeing to let you attend the meeting."
"However, firstly, you have made a contribution, and secondly, your paper on the derivation of Isolated Point Particle and Mersenne prime is objectively of great academic value."
"Judging solely from achievements, many recipients of the Excellent Young Scientists Fund, Outstanding Young Scholar, and even a very small number of academicians, do not have as many academic achievements as you."
"So after three meetings, the Chinese Academy of Sciences has decided to give you this opportunity—provided, of course, that your proposal is good enough."
Although Xu Yun was still somewhat lost in thought, he nodded slightly.
He naturally understood this principle.
Although the Chinese Academy of Sciences promised to review his proposal, there will obviously be an internal evaluation process as well.
If it were a project to study how many words a writer could produce if locked in Black Box, the Chinese Academy of Sciences would obviously not approve it.
After a while...
Tian Liangwei glanced at the time and said:
"Little Xu, the list of experts for this year's National Natural Science Foundation of China (NSFC) review will be announced around the end of July. Proposals should be submitted by March 20th, followed by a formal review in April and a written review in early June."
"However, your case allows you to proceed directly to the meeting, so just submit your bid before the review meeting in July."
"You can draft the specific projects yourself, or you can ask University of Science and Technology of China for help. Don't feel too much pressure."
Xu Yun gave a faint "hmm" in response, a multitude of thoughts flashing through his mind in an instant.
When it comes to project proposals, he has many feasible directions in mind.
For example, the safest option is a microbial battery.
Currently, the bio-engineering bacteria strain has been identified as Yi An Jun; the remaining tasks mainly involve improving the efficiency of current capture.
If you focus your efforts, you might even achieve initial results during the initial review process.
There is also the ground state processing of Isolated Point Particle, which involves the Gravity Gradiometer, a project that is nominally legitimate to the extreme.
In addition, MR Technology, hemostatic gel, and DNA storage technology at the end of the Old Su instance are all quite suitable options.
However, the specific choice still needs to be discussed carefully, since applying for the A-level designation for hundreds of people involves not only the honorary recognition but also other resource support.
The Academy of Sciences has quite a few advanced juice processing equipment. Although their unit price may not be as high as several hundred million, some of these devices cannot be measured by their manufacturing cost alone.
For example, the Chinese Academy of Sciences has a multi-axis parallel micro-nano measuring instrument about the size of a microwave oven, which costs only about five million yuan, but its rarity is even greater than that of an aircraft carrier:
There are only two in China; they were developed using an exhaustive search method.
Once we obtain the right to use these instruments...
Slurp.
Xu Yun wiped away non-existent drool from the corner of his mouth, took a deep breath, and looked at Tian Liangwei again:
"Teacher, I will think about this carefully. So, what about the third form of compensation?"
"The third form of compensation."
When the third form of compensation was mentioned, Tian Liangwei's expression suddenly became somewhat subtle, and he changed the subject:
"Little Xu, how much do you know about Advion?"
Xu Yun was taken aback upon hearing this:
"Advion?"
Advion was the foreign company where Corinna Asensio worked, and as one of the colleagues who had sabotaged him, Xu Yun was naturally quite familiar with it.
"Advion is a well-known disinfection and equipment manufacturer Across the sea, formerly a Syngenta."
"But before Syngenta was acquired by Huaxia Chemical in 2017, AstraZeneca had already regained actual control of Advion."
Although Xu Yun spoke calmly, he was still somewhat surprised when he learned about Advion's background—he hadn't expected that Advion would have such a close relationship with AstraZeneca.
AstraZeneca
Despite the similarity in name to Asahi Company, the two are completely different in size, and even on different levels.
AstraZeneca currently has a market capitalization of around $200 billion and annual sales in China approaching $4 billion, making it a true behemoth in the pharmaceutical industry.
Even among the Fortune Global 500, AstraZeneca ranks among the top.
You need to know.
China Construction Bank, one of the four major state-owned banks in Huaxia, has a market capitalization of only 1.3 trillion Huaxia currency.
AstraZeneca is a century-old company. Its predecessor was the Britain Imperial Chemical Industries, which later evolved into Zeneca.
End of 1998.
Zenecan and Sweden's AstraZeneca successfully merged to form AstraZeneca.
Then, on November 13, 2000.
AstraZeneca's agrochemicals business, Zeneca Agrochemicals, and Novartis's crop protection and seed business were spun off from their original companies and merged to form a company focused on agricultural technology.
That is to say...
Syngenta.
Then, in 2011, Syngenta established Advion as a subsidiary.
Later, as the business developed...
Advion Syngenta's system and has begun to design its own instrument development industry.
By 2016.
Huaxia Chemical suddenly broke a big news story:
Sinochem Group will Syngenta for 480 Swiss francs per share in cash, totaling a staggering $43 billion, making it the largest overseas acquisition by Huaxia company.
But few people know this.
Even before the merger took place, Syngenta had transferred Advion to AstraZeneca —because they refused to classify their instrumentation business under the merger agreement.
Similar components are not limited to the instrument module; there are many other parts as well.
In other words, they only sell the business, not the technology.
So even though Advion still carries the Syngenta brand, not a single penny of its profits goes to Huaxia Chemical.
This is somewhat similar to the case of a certain man surnamed Wang and Barbie Hsu (Da S). He sleeps in your house with his lover, spending your money, and even if you want to burn the mattress, it's fireproof!
Okay, let's get back to reality.
Seeing that Xu Yun had clearly explained Advion's situation, Tian Liangwei nodded approvingly and said:
"Very good. Now that you can explain the relationship between Advion and AstraZeneca, the rest should be easier to understand."
He paused, organized his thoughts, and continued:
"Little Xu, I remember you visited the China International Import Expo two years ago, right?"
".?"
Although he didn't know why his mentor had brought up the China International Import Expo again, Xu Yun still answered honestly:
"Yes, I was one of the members of the school's sightseeing tour group back then."
Tian Liangwei nodded and continued:
"In that case, you must have visited that 'HealthTOHO' facility, right?"
"HealthTOHO?"
Xu Yun was startled again, and after regaining his senses, a trace of reminiscence gradually appeared in his eyes:
"Of course I remember."
HealthTOHO.
This is a project in collaboration between Microsoft and AstraZeneca, and a brand new endeavor for Microsoft following HealthVault.
At the 2020 China International Import Expo, this project shone brightly, truly catching the spotlight.
This project represents a brand-new application in the field of smart healthcare. Doctors can remotely control robotic arms to perform surgery simply by wearing MR glasses.
The lung surgery module showcased at the CIIE allows doctors to locate lung nodules in just 5 to 10 minutes and then perform the surgery through a minimal incision.
The overall success rate over the three days was an impressive 97%.
As a biology and physics student, Xu Yun was naturally impressed by HealthTOHO.
Just as Xu Yun was lost in his memories, Tian Liangwei said:
"Little Xu, you may not know this, but the person in charge of the HealthTOHO project is named Lu Xiao, who is also an alumnus of our University of Science and Technology of China of China."
"Later, I went to the Across the sea to pursue my PhD, and after graduating, I stayed at Microsoft —but I didn't immigrate."
Xu Yun immediately raised an eyebrow.
He wasn't surprised that the man named Lu Xiao hadn't returned to China; after all, there were far too many people studying abroad or even immigrating these days.
The income and research environment abroad are indeed quite favorable, but everyone has their own ambitions.
Those who are willing to return to contribute to the country deserve respect, but those who go abroad to work for a living can also be understood.
As long as you don't become a traitor, it'll be fine.
Xu Yun knew many friends who had studied abroad in his previous life, and some of their situations were indeed understandable.
For example, a couple he knew who ran a Chinese restaurant in Iberia couldn't open their business without immigrating, and their taxes were much higher than normal.
If they return to their home country, their income will be several times less.
In this situation, would you say they should immigrate or not?
There are also some research talents whose salaries abroad are several times higher than those in China, which is a very real issue.
Of course.
Those who run off to become lackeys—like Fang Zhouzi—even though he's Xu Yun's classmate, Xu Yun, or rather all the students at University of Science and Technology of China, still despise him immensely.
What Xu Yun truly cared about at this moment was another layer of meaning in Tian Liangwei's words:
"Teacher, could it be that Dr. Lu Xiao?"
Tian Liangwei nodded slightly, confirming his guess:
"That's right. Dr. Lu Xiao wanted to resign and return to China several years ago, but because his research was too cutting-edge, Microsoft, or some higher authorities, were unwilling to let him come back."
"Dr. Lu Xiao, for reasons of personal safety, has no choice but to continue to feign compliance."
"But this time, Advion's Corinna, as the person who proposed the smear campaign in the meeting recording, directly impacted the parent company AstraZeneca —because Corinna directly mentioned AstraZeneca's name during the meeting."
"Therefore, after obtaining Dr. Lu Xiao's consent, the Chinese Academy of Sciences used this as a condition to negotiate with AstraZeneca."
"In the end, AstraZeneca reluctantly agreed to the request and negotiated with Microsoft —after all, this was originally a collaborative project between AstraZeneca and Microsoft."
"So, Little Xu."
At this point, Tian Liangwei couldn't help but glance at Xu Yun again:
"This is the third great gift the Academy of Sciences has given you: a top expert in biointelligence."